Status: Not yet recruiting
An Open-label Long-term Safety Study of Buntanetap in Participants With AD
This study will examine the long-term safety of buntanetap in participants with AD who have participated in a prior study of buntanetap in AD.
Participants needed: 400
Trial details
Phase: Phase 2, Phase 3Age: 55+Biological sex: AllType: InterventionalSponsor: Annovis Bio Inc.Updated: Aug 19, 2026
Eligibility criteria
Has participated in a prior Alzheimer's clinical trial with buntanetap. [+8]
Has history of psychiatric disorder such as schizophrenia, bipolar disorder, or... [+22]